San Francisco, California--(Newsfile Corp. - August 26, 2025) - A New York federal court has re-opened the lead plaintiff process in the Spectrum Pharmaceuticals ( SPPI ) securities class action, offering a new opportunity for investors to represent the class. The action follows the court's decision on August 4, 2025, to disqualify the previously appointed lead plaintiff. The new deadline to apply is September 24, 2025.